• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Tuesday 05/22/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Medical

  • 5:08 PM

    MINNEAPOLIS, May 10, 2018 (GLOBE NEWSWIRE) — Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery and producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announced today that it expects to secure its first European sales of the STREAMWAY® Systems in the second half of 2018. Based on the interest generated to date, and the stage of negotiations with several potential customers, the Company expects these

    Read more
  • 9:50 AM

    MINNEAPOLIS, May 08, 2018 (GLOBE NEWSWIRE) — Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that management will report its financial results for the fiscal first quarter of 2018 on May 15, 2018 after U.S. markets close. Management will also hold a conference call to provide a general business update and discuss upcoming milestones. The conference call is scheduled to begin at 4:30 p.m. Eastern Time. A

    Read more
  • 10:26 AM

    Santa Monica, CA, May 01, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company closed a private placement with proceeds of $4,789,510. Combined with the closing of our February 2018 placement, the Company has raised $6,289,510 in 2018. The Company issued 3,193,004 common shares at a price of $1.50 per share and

    Read more
  • 8:27 AM

    MINNEAPOLIS, (GLOBE NEWSWIRE) — Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that it has signed an LOI to acquire the remainder of the equity in Helomics Corporation® not currently owned by Precision Therapeutics. Under the terms of the agreement, a newly formed, wholly owned subsidiary of Precision Therapeutics will merge with and into Helomics Corporation, thereby increasing Precision’s equity stake in Helomics from 25% to 100%.

    Read more
  • 8:16 AM

    ORLANDO, Fla., April 26, 2018 (GLOBE NEWSWIRE) — via OTC PR WIRE– Immune Therapeutics, Inc. (OTCQB:IMUN) (“Immune” “IMUN” or the “Company”), a clinical late stage biopharmaceutical company focused on the development of therapies for the treatment of autoimmune diseases, inflammatory diseases, cancer and HIV/AIDS, is pleased to announce that the Kenya Pharmacy and Poison Board filed IMUN’s New Drug Application (NDA) for Lodonal™, its lead drug candidate, thereby accepting the NDA for a full review. Kenya is experiencing an HIV

    Read more
  • 9:16 AM

    Blockchain holding company to take equity position in leading U.S. based enterprise-level blockchain health data company PR Newswire LAS VEGAS and MANHATTAN BEACH, Calif., April 25, 2018 LAS VEGAS and MANHATTAN BEACH, Calif., April 25, 2018 /PRNewswire/ — Millennium BlockChain Inc. (OTC: MBLC) (the “Company”), a holding company focused on blockchain technologies and crypto-assets, today announced the closing of its $5 million investment in HIPAA-compliant enterprise-level blockchain data leader BurstIQ Analytics Corporation (“BurstIQ“). BurstIQ offers a proprietary, HIPAA-compliant enterprise-level blockchain data platform that is purpose-built to

    Read more
Public Wire Banner